Epidemiology of the metabolic syndrome and the RISC study

[1] The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome.: The French DESIR study [J]. DIABETES & METABOLISM, 2003, 29 (05) : 526 - 532

[2] Balkau B, 1999, DIABETIC MED, V16, P442

[3] Balkau B, 2002, DIABETES METAB, V28, P364

[4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497

[5] A comparison of the prevalence of the metabolic syndrome using two proposed definitions [J]. DIABETES CARE, 2003, 26 (03) : 575 - 581

[6] Gavin JR, 1997, DIABETES CARE, V20, P1183

[7] GOMILA S, 2003, MED NUTR, V39, P89

[8] PROSPECTIVE ANALYSIS OF THE INSULIN-RESISTANCE SYNDROME (SYNDROME-X) [J]. DIABETES, 1992, 41 (06) : 715 - 722

[9] The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives [J]. DIABETOLOGIA, 2004, 47 (03) : 566 - 570

[10] HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J]. DIABETOLOGIA, 1985, 28 (07) : 412 - 419

[1] The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome.: The French DESIR study [J]. DIABETES & METABOLISM, 2003, 29 (05) : 526 - 532

[2] Balkau B, 1999, DIABETIC MED, V16, P442

[3] Balkau B, 2002, DIABETES METAB, V28, P364

[4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497

[5] A comparison of the prevalence of the metabolic syndrome using two proposed definitions [J]. DIABETES CARE, 2003, 26 (03) : 575 - 581

[6] Gavin JR, 1997, DIABETES CARE, V20, P1183

[7] GOMILA S, 2003, MED NUTR, V39, P89

[8] PROSPECTIVE ANALYSIS OF THE INSULIN-RESISTANCE SYNDROME (SYNDROME-X) [J]. DIABETES, 1992, 41 (06) : 715 - 722

[9] The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives [J]. DIABETOLOGIA, 2004, 47 (03) : 566 - 570

[10] HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J]. DIABETOLOGIA, 1985, 28 (07) : 412 - 419